Centessa Pharmaceuticals PLC ADR
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $15,000 | $952 | $0 |
Gross Profit | -228 | 15,000 | 476 | -238 |
EBITDA | -46,455 | -21,644 | -106,573 | -39,566 |
EBIT | -46,681 | -21,861 | -106,800 | -39,805 |
Net Income | -50,343 | -26,135 | -111,329 | -42,566 |
Net Change In Cash | 0 | 15,000 | 952 | 0 |
Free Cash Flow | -22,578 | -57,246 | -42,800 | -21,423 |
Cash | 44,242 | 105,156 | 383,221 | 395,026 |
Basic Shares | 133,677 | 133,034 | 132,050 | 116,254 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $6,853 | $0 |
Gross Profit | -942 | 6,853 | -131 |
EBITDA | -221,974 | -166,066 | -207,810 |
EBIT | -222,916 | -166,879 | -207,940 |
Net Income | -235,757 | -151,085 | -216,207 |
Net Change In Cash | 0 | 6,853 | 0 |
Free Cash Flow | -142,089 | -160,511 | -201,683 |
Cash | 383,221 | 128,030 | 393,644 |
Basic Shares | 114,473 | 96,178 | 93,401 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.38 |
2025-03-31 | -$0.20 |
2024-12-31 | -$0.84 |
